---
schema_version: "secwatch.filing_event.v1"
accession: "0000200406-24-000053"
form_type: "8-K"
ticker: "JNJ"
cik: "0000200406"
company_name: "JOHNSON & JOHNSON"
filed_at: "2024-05-17T23:59:59+00:00"
generated_at: "2026-06-01T17:23:22.519846+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Johnson & Johnson fully divests remaining Kenvue stake via debt-for-equity exchange

## Summary
- On May 17, 2024, JNJ exchanged its remaining 182.3M Kenvue shares for $3.6B commercial paper, eliminating its Kenvue ownership.
- JNJ issued $3.6B commercial paper on May 15, 2024 for general corporate purposes, then used it to complete the exchange.
- This completes the separation of Consumer Health business announced in Nov 2021; JNJ no longer holds any Kenvue shares.
- The commercial paper was satisfied and discharged upon completion of the exchange.

## SEC filing metadata
- accession: 0000200406-24-000053
- form_type: 8-K
- ticker: JNJ
- cik: 0000200406
- company_name: JOHNSON & JOHNSON
- filed_at: 2024-05-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/200406/000020040624000053/0000200406-24-000053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/200406/000020040624000053/jnj-20240517.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000200406-24-000053
- JSON: https://secwatch.observer/filing/0000200406-24-000053.json
- Plain text: https://secwatch.observer/filing/0000200406-24-000053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.